The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
HPV Therapeutic Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Human papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global HPV Therapeutic Vaccines market size is expected to reach US$ 12480 million by 2029, growing at a CAGR of 15.9% from 2023 to 2029. The market is mainly driven by the significant applications of HPV Therapeutic Vaccines in various end use industries. The expanding demands from the Man and Woman, are propelling HPV Therapeutic Vaccines market. Bivalent HPV vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Quadrivalent HPV vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HPV Therapeutic Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HPV Therapeutic Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HPV Therapeutic Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HPV Therapeutic Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HPV Therapeutic Vaccines covered in this report include Merck & Co., Inc, GlaxoSmithKline plc, Shanghai Bovax Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB, ISA Pharmaceuticals, Pfizer, Sanofi Pasteur and Serum Institute, etc.
The global HPV Therapeutic Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Pfizer
Sanofi Pasteur
Serum Institute
Emergent BioSolutions
Astellas Pharma
Johnson and Johnson.
Wantai BioPharm
INOVIO Pharmaceuticals
Global HPV Therapeutic Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HPV Therapeutic Vaccines market, Segment by Type:
Bivalent HPV vaccine
Quadrivalent HPV vaccine
Global HPV Therapeutic Vaccines market, by Application
Man
Woman
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HPV Therapeutic Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Human papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global HPV Therapeutic Vaccines market size is expected to reach US$ 12480 million by 2029, growing at a CAGR of 15.9% from 2023 to 2029. The market is mainly driven by the significant applications of HPV Therapeutic Vaccines in various end use industries. The expanding demands from the Man and Woman, are propelling HPV Therapeutic Vaccines market. Bivalent HPV vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Quadrivalent HPV vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HPV Therapeutic Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global HPV Therapeutic Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HPV Therapeutic Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HPV Therapeutic Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HPV Therapeutic Vaccines covered in this report include Merck & Co., Inc, GlaxoSmithKline plc, Shanghai Bovax Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB, ISA Pharmaceuticals, Pfizer, Sanofi Pasteur and Serum Institute, etc.
The global HPV Therapeutic Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Pfizer
Sanofi Pasteur
Serum Institute
Emergent BioSolutions
Astellas Pharma
Johnson and Johnson.
Wantai BioPharm
INOVIO Pharmaceuticals
Global HPV Therapeutic Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HPV Therapeutic Vaccines market, Segment by Type:
Bivalent HPV vaccine
Quadrivalent HPV vaccine
Global HPV Therapeutic Vaccines market, by Application
Man
Woman
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of HPV Therapeutic Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of HPV Therapeutic Vaccines
1.1 HPV Therapeutic Vaccines Market Overview
1.1.1 HPV Therapeutic Vaccines Product Scope
1.1.2 HPV Therapeutic Vaccines Market Status and Outlook
1.2 Global HPV Therapeutic Vaccines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HPV Therapeutic Vaccines Market Size by Region (2018-2029)
1.4 Global HPV Therapeutic Vaccines Historic Market Size by Region (2018-2023)
1.5 Global HPV Therapeutic Vaccines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.1 North America HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.2 Europe HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.3 Asia-Pacific HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.4 Latin America HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.5 Middle East & Africa HPV Therapeutic Vaccines Market Size (2018-2029)
2 HPV Therapeutic Vaccines Market by Type
2.1 Introduction
2.1.1 Bivalent HPV vaccine
2.1.2 Quadrivalent HPV vaccine
2.2 Global HPV Therapeutic Vaccines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HPV Therapeutic Vaccines Historic Market Size by Type (2018-2023)
2.2.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
3 HPV Therapeutic Vaccines Market Overview by Application
3.1 Introduction
3.1.1 Man
3.1.2 Woman
3.2 Global HPV Therapeutic Vaccines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HPV Therapeutic Vaccines Historic Market Size by Application (2018-2023)
3.2.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
4 HPV Therapeutic Vaccines Competition Analysis by Players
4.1 Global HPV Therapeutic Vaccines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2022)
4.3 Date of Key Players Enter into HPV Therapeutic Vaccines Market
4.4 Global Top Players HPV Therapeutic Vaccines Headquarters and Area Served
4.5 Key Players HPV Therapeutic Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 HPV Therapeutic Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck & Co., Inc
5.1.1 Merck & Co., Inc Profile
5.1.2 Merck & Co., Inc Main Business
5.1.3 Merck & Co., Inc HPV Therapeutic Vaccines Products, Services and Solutions
5.1.4 Merck & Co., Inc HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.1.5 Merck & Co., Inc Recent Developments
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Profile
5.2.2 GlaxoSmithKline plc Main Business
5.2.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Products, Services and Solutions
5.2.4 GlaxoSmithKline plc HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline plc Recent Developments
5.3 Shanghai Bovax Biotechnology Co., Ltd.
5.3.1 Shanghai Bovax Biotechnology Co., Ltd. Profile
5.3.2 Shanghai Bovax Biotechnology Co., Ltd. Main Business
5.3.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Products, Services and Solutions
5.3.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.3.5 Profectus BioSciences, Inc. Recent Developments
5.4 Profectus BioSciences, Inc.
5.4.1 Profectus BioSciences, Inc. Profile
5.4.2 Profectus BioSciences, Inc. Main Business
5.4.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Products, Services and Solutions
5.4.4 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.4.5 Profectus BioSciences, Inc. Recent Developments
5.5 2A Pharma AB
5.5.1 2A Pharma AB Profile
5.5.2 2A Pharma AB Main Business
5.5.3 2A Pharma AB HPV Therapeutic Vaccines Products, Services and Solutions
5.5.4 2A Pharma AB HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.5.5 2A Pharma AB Recent Developments
5.6 ISA Pharmaceuticals
5.6.1 ISA Pharmaceuticals Profile
5.6.2 ISA Pharmaceuticals Main Business
5.6.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
5.6.4 ISA Pharmaceuticals HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.6.5 ISA Pharmaceuticals Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer HPV Therapeutic Vaccines Products, Services and Solutions
5.7.4 Pfizer HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Sanofi Pasteur
5.8.1 Sanofi Pasteur Profile
5.8.2 Sanofi Pasteur Main Business
5.8.3 Sanofi Pasteur HPV Therapeutic Vaccines Products, Services and Solutions
5.8.4 Sanofi Pasteur HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Pasteur Recent Developments
5.9 Serum Institute
5.9.1 Serum Institute Profile
5.9.2 Serum Institute Main Business
5.9.3 Serum Institute HPV Therapeutic Vaccines Products, Services and Solutions
5.9.4 Serum Institute HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.9.5 Serum Institute Recent Developments
5.10 Emergent BioSolutions
5.10.1 Emergent BioSolutions Profile
5.10.2 Emergent BioSolutions Main Business
5.10.3 Emergent BioSolutions HPV Therapeutic Vaccines Products, Services and Solutions
5.10.4 Emergent BioSolutions HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.10.5 Emergent BioSolutions Recent Developments
5.11 Astellas Pharma
5.11.1 Astellas Pharma Profile
5.11.2 Astellas Pharma Main Business
5.11.3 Astellas Pharma HPV Therapeutic Vaccines Products, Services and Solutions
5.11.4 Astellas Pharma HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.11.5 Astellas Pharma Recent Developments
5.12 Johnson and Johnson.
5.12.1 Johnson and Johnson. Profile
5.12.2 Johnson and Johnson. Main Business
5.12.3 Johnson and Johnson. HPV Therapeutic Vaccines Products, Services and Solutions
5.12.4 Johnson and Johnson. HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.12.5 Johnson and Johnson. Recent Developments
5.13 Wantai BioPharm
5.13.1 Wantai BioPharm Profile
5.13.2 Wantai BioPharm Main Business
5.13.3 Wantai BioPharm HPV Therapeutic Vaccines Products, Services and Solutions
5.13.4 Wantai BioPharm HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.13.5 Wantai BioPharm Recent Developments
5.14 INOVIO Pharmaceuticals
5.14.1 INOVIO Pharmaceuticals Profile
5.14.2 INOVIO Pharmaceuticals Main Business
5.14.3 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
5.14.4 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.14.5 INOVIO Pharmaceuticals Recent Developments
6 North America
6.1 North America HPV Therapeutic Vaccines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HPV Therapeutic Vaccines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HPV Therapeutic Vaccines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HPV Therapeutic Vaccines Market Dynamics
11.1 HPV Therapeutic Vaccines Industry Trends
11.2 HPV Therapeutic Vaccines Market Drivers
11.3 HPV Therapeutic Vaccines Market Challenges
11.4 HPV Therapeutic Vaccines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
